
Dr Mittal Laboratories Private Limited
Produces various pharmaceutical drugs and tablets, GMP certified, established in 2005.
Produces various pharmaceutical drugs and tablets, GMP certified, established in 2005.
Dr Mittal Laboratories Private Limited (DMLPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 December 2005 and has a history of 19 years and two months. Its registered office is in Dehradun, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.50 M.
The company has closed loans amounting to ₹1.83 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Akansha Gupta, Bhuwan Pathak, and Ankit Gupta serve as directors at the Company.
Dehradun, Uttarakhand, India
+91-XXXXXXXXXX
U24234UR2005PTC031167
031167
Private Limited Indian Non-Government Company
29 Dec 2005
30 Sep 2024
31 Mar 2024
Unlisted
Roc Uttarakhand
Dr Mittal Laboratories Private Limited offers a wide range of products and services, including Veterinary Medicines, Anthelmintics, Pharmaceutical Medicine, Antiepileptic Drugs.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Akansha Gupta ![]() | Additional Director | 20-Oct-2022 | Current |
Bhuwan Pathak ![]() | Additional Director | 16-Aug-2024 | Current |
Ankit Gupta ![]() | Additional Director | 15-Oct-2016 | Current |
Dr Mittal Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.86% decrease. The company also saw a substantial fall in profitability, with a 87.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 56.53%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Dr Mittal Laboratories had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Ankit Gupta is a mutual person
Akansha Gupta and Ankit Gupta are mutual person
Akansha Gupta and Ankit Gupta are mutual person
Akansha Gupta and Ankit Gupta are mutual person
Ankit Gupta is a mutual person
Ankit Gupta is a mutual person
₹0
₹18.25 M
Date | Lender | Amount | Status |
---|---|---|---|
12 Feb 2009 | Punjab National Bank | ₹1.00 M | Satisfied |
22 Nov 2008 | Punjab National Bank | ₹0.75 M | Satisfied |
03 Oct 2006 | Punjab National Bank | ₹5.00 M | Satisfied |
03 Oct 2006 | Punjab National Bank | ₹1.15 Cr | Satisfied |
Unlock and access historical data on people associated with Dr Mittal Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dr Mittal Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Mittal Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dr Mittal Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Bhuwan Chandra Pathak was appointed as a Additional Director was appointed as a Additional Director on 16 Aug 2024 & has been associated with this company since 6 months 26 days .
Dr Mittal Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand.
A charge registered on 03 Oct 2006 via Charge ID 10025385 with Punjab National Bank was fully satisfied on 27 Mar 2023.
Akansha Gupta was appointed as a Additional Director was appointed as a Additional Director on 20 Oct 2022 & has been associated with this company since 2 years 4 months .
Ankit Gupta was appointed as a Additional Director was appointed as a Additional Director on 15 Oct 2016 & has been associated with this company since 8 years 4 months .
Dr Mittal Laboratories Private Limited was incorporated on 29 Dec 2005.
The authorized share capital of Dr Mittal Laboratories Private Limited is ₹ 5.00 M and paid-up capital is ₹ 3.50 M.
Currently 3 directors are associated with Dr Mittal Laboratories Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Dr Mittal Laboratories Private Limited is C-10/2 Sara Industrial Estate Ltd. Vill. Rampur, 23Rd Km. Selaqui India, Dehradun, Uttarakhand, 248197.
The corporate identification number (CIN) of Dr Mittal Laboratories Private Limited is U24234UR2005PTC031167 and the company number is 031167 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Dr Mittal Laboratories Private Limited has fallen by -33.86%.
The financial reports for the fiscal year 2023 indicates that The net worth of Dr Mittal Laboratories Private Limited has experienced an downturn of -56.53%.
The most recent Balance Sheet for Dr Mittal Laboratories Private Limited was filed with the ROC on 31 Mar 2024.
SM
JM
SG
CP
KP
MM
RP
RP